EIP
Epoch Investment Partners Portfolio holdings
AUM
$19.3B
This Quarter Return
-11.23%
1 Year Return
+19.15%
3 Year Return
+76.35%
5 Year Return
+147.93%
10 Year Return
+300.25%
AUM
$21.5B
AUM Growth
+$21.5B
(-18%)
Cap. Flow
-$1.54B
Cap. Flow
% of AUM
-7.13%
Top 10 Holdings %
Top 10 Hldgs %
19.22%
Holding
321
New
14
Increased
99
Reduced
180
Closed
23
Top Buys
| 1 |
CVS Health
CVS
|
$241M |
| 2 |
Linde
LIN
|
$237M |
| 3 |
Abbott
ABT
|
$128M |
| 4 |
Hexcel
HXL
|
$114M |
| 5 |
Amgen
AMGN
|
$86M |
Top Sells
| 1 |
Home Depot
HD
|
$218M |
| 2 |
Johnson Controls International
JCI
|
$152M |
| 3 |
DuPont de Nemours
DD
|
$116M |
| 4 |
Starbucks
SBUX
|
$93.8M |
| 5 |
Universal Display
OLED
|
$87.9M |
Sector Composition
| 1 | Healthcare | 15.65% |
| 2 | Technology | 15.53% |
| 3 | Financials | 14.89% |
| 4 | Industrials | 9.94% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.77T
| $814M | 3.78% | 8,011,089 -485,230 | -6% | -$49.3M |
|
2
Apple
AAPL
$3.45T
| $453M | 2.1% | 2,869,514 -152,548 | -5% | -$24.1M |
|
3
UnitedHealth
UNH
$281B
| $449M | 2.09% | 1,801,762 -239,507 | -12% | -$59.7M |
|
4
Pfizer
PFE
$141B
| $414M | 1.92% | 9,478,671 -1,036,313 | -10% | -$45.2M |
|
5
Occidental Petroleum
OXY
$46.9B
| $386M | 1.79% | 6,284,867 -819,527 | -12% | -$50.3M |
|
|
6
DuPont de Nemours
DD
$32.2B
| $345M | 1.6% | 6,449,665 -2,166,459 | -25% | -$116M |
|
7
Merck
MRK
$210B
| $344M | 1.6% | 4,505,056 -255,933 | -5% | -$19.6M |
|
8
Alphabet (Google) Class C
GOOG
$2.58T
| $335M | 1.56% | 323,877 -43,120 | -12% | -$44.7M |
|
9
Duke Energy
DUK
$95.3B
| $305M | 1.42% | 3,536,633 -429,058 | -11% | -$37M |
|
10
MetLife
MET
$54.1B
| $293M | 1.36% | 7,134,180 -1,495,789 | -17% | -$61.4M |
|
11
Applied Materials
AMAT
$128B
| $287M | 1.33% | 8,765,183 -26,484 | -0.3% | -$867K |
|
12
Verizon
VZ
$186B
| $273M | 1.27% | 4,852,638 -1,506,008 | -24% | -$84.7M |
|
13
Costco
COST
$418B
| $269M | 1.25% | 1,322,945 +344,101 | +35% | +$70.1M |
|
14
Danaher
DHR
$147B
| $261M | 1.21% | 2,534,599 -659,044 | -21% | -$68M |
|
15
Visa
V
$683B
| $261M | 1.21% | 1,974,425 -659,216 | -25% | -$87M |
|
|
16
CVS Health
CVS
$92.8B
| $254M | 1.18% | 3,872,700 +3,679,925 | +1,909% | +$241M |
|
|
17
Hexcel
HXL
$5.02B
| $253M | 1.18% | 4,420,788 +1,985,300 | +82% | +$114M |
|
18
Morgan Stanley
MS
$240B
| $253M | 1.17% | 6,371,451 -880,552 | -12% | -$34.9M |
|
19
CME Group
CME
$96B
| $251M | 1.17% | 1,334,594 -123,054 | -8% | -$23.1M |
|
20
Martin Marietta Materials
MLM
$37.2B
| $244M | 1.13% | 1,418,827 -21,843 | -2% | -$3.75M |
|
|
21
Linde
LIN
$224B
| $237M | 1.1% | +1,520,929 | New | +$237M |
|
22
Bank of America
BAC
$376B
| $234M | 1.09% | 9,515,758 -810,355 | -8% | -$20M |
|
23
Welltower
WELL
$113B
| $233M | 1.08% | 3,356,105 -556,529 | -14% | -$38.6M |
|
|
RDS.A
24
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $230M | 1.07% | 3,953,856 -506,785 | -11% | -$29.5M |
|
25
AstraZeneca
AZN
$248B
| $229M | 1.06% | 6,031,952 -1,507,433 | -20% | -$57.3M |
|